Adverse Drug Events in Hospitalized Patients

JAMA: The Journal of the American Medical Association

Volumn 277, Issue 17, 1997, Pages 1352-1353

  Schneeweiss, Sebastian G ^a   Goettler, Martin ^a   Hasford, Joerg ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

DRUG THERAPY; ECONOMICS; HOSPITALIZATION; HUMAN; NOTE;

DRUG THERAPY; HOSPITALIZATION; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 0031557832     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03540410030016     Document Type: Letter

References (3)

1. Bates DW, Spell N, Cullen DJ, et al, for the Adverse Drug Event Prevention Study Group. The costs of adverse drug events in hospitalized patients. JAMA. 1997;277:307-311.
2. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. JAMA. 1997;277:301-306.
3. Muehlberger N, Schneeweiss S, Hasford J. Adverse drug reaction monitoring cost and benefit considerations part 1: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol and Drug Safety. 1997;In press.